Provided by Tiger Trade Technology Pte. Ltd.

HANSOH PHARMA

34.340
+0.3401.00%
Volume:5.89M
Turnover:202.62M
Market Cap:208.24B
PE:31.55
High:34.680
Open:34.000
Low:33.420
Close:34.000
52wk High:43.939
52wk Low:27.882
Shares:6.06B
HK Float Shares:6.06B
Volume Ratio:0.54
T/O Rate:0.10%
Dividend:0.43
Dividend Rate:1.26%
EPS(LYR):1.088
ROE:19.40%
ROA:9.08%
PB:4.71
PE(LYR):31.55
PS:11.19

Loading ...

Movement Alert|Hansoh Pharmaceutical Falls 3.03% in Regular Trading, Pharmaceutical Sector Under Broad Selling Pressure

Market Focus
·
Jun 30

Hansoh Pharmaceutical Group Stock Rises 5.8% in Hong Kong

Dow Jones
·
Jun 29

Movement Alert|Hansoh Pharmaceutical Rises 4.88% in Regular Trading, Pharma Sector Rally Combines with Dense Pipeline Catalysts

Market Focus
·
Jun 29

Hansoh Pharma Shareholders Approved 2026 Share Scheme at AGM

Reuters
·
Jun 26

Hansoh Pharmaceutical Group Stock Slides 1.3% in Hong Kong

Dow Jones
·
Jun 24

Movement Alert|Hansoh Pharmaceutical Rises 3.18% in Regular Trading, Receives Inaugural Buy Rating from Guosheng Securities

Market Focus
·
Jun 24

Hansoh Pharmaceutical Group (SEHK:3692) Stock Could Be Below Fair Value After Hang Seng Index Inclusion

Simply Wall St.
·
Jun 21

Hansoh Pharma releases in vitro study data on HS-20094 dual-biased GLP-1/GIP agonist at ENDO 2026

Reuters
·
Jun 16

Hansoh Pharmaceutical Group Stock Rallies 2.6% in Hong Kong

Dow Jones
·
Jun 12

Hansoh Pharma posts 80% MMR at week 48 in phase 1b HS-10382 plus flumatinib trial for newly diagnosed CML-CP

Reuters
·
Jun 12

Hansoh Pharmaceutical Group (SEHK:3692) Valuation Check After Hang Seng China Enterprises Index Inclusion

Simply Wall St.
·
Jun 11

Hansoh Pharma Appoints Guo Ying as Joint Company Secretary Following Zhong Shengli’s Resignation

Bulletin Express
·
Jun 10

Hansoh Pharma’s NDA for HS-10568 Injection Accepted by China’s NMPA

Bulletin Express
·
Jun 10

HANSOH PHARMA Receives NMPA Acceptance for New Drug Application of HS-10568 Injection

Stock News
·
Jun 10

Hansoh Pharma says China regulator accepts NDA for HS-10568 injection in kidney disease complication

Reuters
·
Jun 10

Hansoh Pharmaceutical - Nda for Hs-10,568 Injection Accepted by Nmpa of China for Shpt in Adult Ckd Patients

THOMSON REUTERS
·
Jun 10

HANSOH PHARMA Announces Appointment of Guo Ying as Joint Company Secretary

Stock News
·
Jun 10

Hansoh Pharmaceutical Group Stock Rises 2.6% in Hong Kong

Dow Jones
·
Jun 10

Hansoh Pharmaceutical Group Stock Falls 1.8% in Hong Kong

Dow Jones
·
Jun 08

Hansoh Pharmaceutical Group Stock Sheds 1.6% in Hong Kong

Dow Jones
·
Jun 05